A detailed history of Security Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Security Asset Management holds 3,000 shares of AMGN stock, worth $790,140. This represents 0.43% of its overall portfolio holdings.

Number of Shares
3,000
Previous 3,035 1.15%
Holding current value
$790,140
Previous $797,000 9.03%
% of portfolio
0.43%
Previous 0.44%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $7,902 - $9,632
-35 Reduced 1.15%
3,000 $725,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $458 - $582
2 Added 0.07%
3,035 $797,000
Q3 2022

Nov 02, 2022

BUY
$224.46 - $253.15 $224 - $253
1 Added 0.03%
3,033 $684,000
Q2 2022

Aug 02, 2022

BUY
$230.71 - $256.74 $24,455 - $27,214
106 Added 3.62%
3,032 $738,000
Q1 2022

May 02, 2022

SELL
$219.27 - $242.57 $20,611 - $22,801
-94 Reduced 3.11%
2,926 $708,000
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $81,143 - $92,860
-408 Reduced 11.9%
3,020 $679,000
Q3 2021

Oct 26, 2021

BUY
$212.27 - $248.7 $212 - $248
1 Added 0.03%
3,428 $729,000
Q2 2021

Jul 27, 2021

SELL
$233.58 - $259.14 $9,109 - $10,106
-39 Reduced 1.13%
3,427 $835,000
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $221 - $258
1 Added 0.03%
3,466 $862,000
Q4 2020

Feb 01, 2021

BUY
$216.38 - $257.67 $129,828 - $154,602
600 Added 20.94%
3,465 $797,000
Q3 2020

Nov 02, 2020

SELL
$234.65 - $260.95 $196,167 - $218,154
-836 Reduced 22.59%
2,865 $728,000
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $35,340 - $41,426
-212 Reduced 5.42%
3,701 $682,000
Q3 2018

Oct 26, 2018

SELL
$185.29 - $208.89 $4,817 - $5,431
-26 Reduced 0.66%
3,913 $811,000
Q4 2017

Jan 26, 2018

SELL
$168.79 - $188.59 $47,598 - $53,182
-282 Reduced 6.68%
3,939 $685,000
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $706,131 - $806,211
4,221
4,221 $787,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Security Asset Management Portfolio

Follow Security Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Security Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Security Asset Management with notifications on news.